Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers

European Meeting on HIV & Hepatitis 2021

Virological characterization of treatment failures and retreatment outcomes in patients infected with “unusual” HCV genotype 1 subtypes

European Meeting on HIV & Hepatitis 2022

Injectable ART: Advantages and disadvantages | Michael Saag, MD

HIV DART and Emerging Viruses 2018

Efavirenz‐based therapy may simplify antiretroviral LPV‐based therapy initiated in HIV‐1‐infected children before the age of 2 in West‐Africa: the MONOD trial ANRS 12206 - Valeriane Leroy

International Workshop on HIV & Pediatrics 2015

Current Status of HIV in Ghana - Kyeremeh Atuahene

INTEREST 2019

Sex work in sub-Saharan Africa | Isidore Traoré, MD, PhD

INTEREST 2016

Local Situation in Puerto Rico: Epidemiology and Treatment Options - Jorge Santana, MD

Local Situation in Puerto Rico: Epidemiology and Treatment Options- Jorge Santana-Bagur, MD

Puerto Rico Meeting on Hepatitis & HIV 2019

Transmitted drug resistance to integrase based first-line treatment in Europe, 2018-2021

European Meeting on HIV & Hepatitis 2022

Pharmacokinetic and virological efficacy of dolutegravir (50 mg BID) containing regimen in association with rifampin in HIV-infected patients using Dried Blood Spot: ANRS-12313 NAMSAL sub-study in Cameroon- Le

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018